Hosted on MSN3mon
Maze Therapeutics raises $115m to advance kidney disease candidatesMaze Therapeutics has completed a Series D financing round, raising $115m to propel the development of its lead candidates, MZE829 and MZE782. The financing round included the conversion of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback